Harbour Investments, Inc. Lantern Pharma Inc. Transaction History

Harbour Investments, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 16, 2022	SELL	$7.11 - $11.04 $220 - $342	-31 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$10.53 - $14.93 $147 - $209	-14 Reduced 31.11%	31 $0
Q2 2021 Aug 16, 2021	BUY	$12.94 - $19.89 $25 - $39	2 Added 4.65%	45 $1,000
Q1 2021 Aug 17, 2021	BUY	$14.34 - $21.92 $602 - $920	42 Added 4200.0%	43 $1,000
Q1 2021 May 12, 2021	BUY	$14.34 - $21.92 $14 - $21	1 New	1 $0

1.31M

39.8K

6.1K

Ticker LTRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 10,830,900
Market Cap $37M
Description
Lantern Pharma Inc., a clinical stage biotechnology company, focuses on artificial intelligence, machine learning, and genomic data to streamline the drug development process. Its advanced drug candidate is LP-100, which is in phase II clinical trials to treat metastatic, castration-resistant, and prostate cancer. The company also develops LP-30...

Get notified when there are updates to the investment portfolio of Harbour Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on Harbour Investments, Inc. with notifications on news.